Published by Coherent Market Insights
Posted on September 21, 2021
Coherent Market Insights report on the Near Patient Molecular Solution Market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period from 2021 to 2027. The report provides the overall market value of the Near Patient Molecular Solution Market for the period of 2021 to 2027, with 2020 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the Near Patient Molecular Solution Market for the forecast period.
The PDF for the study can be requested using the following link: https://www.coherentmarketinsights.com/insight/request-pdf/47
Near patient molecular solutions, also known as point-of-use diagnosis, is an innovative technology which helps to diagnose and measure health in the very private and personal comfort of the individual. The main motive is to offer patients easy access to necessary testing services, with fast turnaround times and accurate outcomes as compared to that provided by traditional laboratory-based tests. This diagnostic method helps to maintain a healthy environment at all times, even while undergoing medical procedures. It is extremely helpful in detecting any health conditions beforehand, before any such conditions cause severe discomfort to a patient. In June 2021, a major diagnostic testing solutions provider, Meridian BioScience, launched the Lyo-Ready RT-LAMP Mix for molecular detection of RNA viruses.
In recent years, near patient molecular solutions have emerged to address the medical concerns of individuals living in different regions and diseases affecting the human body. The main purpose of these products is to monitor the health of an individual as he or she travels across regions or crosses the border from one country to another. Depending on the disease concerned, the products are designed to be compatible with the standards of the healthcare organization of the country from where the individual has moved. The products are made available for use in clinical trials conducted by pharmaceutical companies and other institutions. In June 2021, the diagnostic testing company, BGI Americas, partnered with Advaite, a bio-tech company, to enhance the molecular testing solutions of the former.
Some of the factors pushing the near patient molecular solution market are increased use of residence point-of-care equipment, technological advancements with a trend for quicker and easier-to-use devices, and the rising rates of illnesses such as heart disease and diabetes in emerging nations. Additionally, the near patient molecular solution market is being propelled by the higher demand for home healthcare services and an increase in the number of geriatric patients with various chronic diseases.
Based on regions, North America led the near patient molecular solution market in the view of favorable reimbursement rules for diagnostic techniques and a large number of clinical trials examining the efficacy. Similarly, the lack of clinical diagnosing facilities have paved a way for local participants to provide near patient monitoring in the Asia Pacific region, which is projected to broaden the growth aspects of the near patient molecular solution market.
However, due to a decrease in the number of patient visits and the fact that hospitals have redirected their healthcare supplies and priority to the administration of COVID-19 cases, there has been a considerable drop in demand for regular diagnostic testing equipment or kits.
Top Key Players Include In Near Patient Molecular Solution Market: Abbott Laboratories, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., and GenMark Diagnostics.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/47
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Near Patient Molecular Solution Market is Growing Rapidly with Current and Future Business Opportunities appeared first on Gatorledger.
Coherent Market Insights report on the Near Patient Molecular Solution Market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period from 2021 to 2027. The report provides the overall market value of the Near Patient Molecular Solution Market for the period of 2021 to 2027, with 2020 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the Near Patient Molecular Solution Market for the forecast period.
The PDF for the study can be requested using the following link: https://www.coherentmarketinsights.com/insight/request-pdf/47
Near patient molecular solutions, also known as point-of-use diagnosis, is an innovative technology which helps to diagnose and measure health in the very private and personal comfort of the individual. The main motive is to offer patients easy access to necessary testing services, with fast turnaround times and accurate outcomes as compared to that provided by traditional laboratory-based tests. This diagnostic method helps to maintain a healthy environment at all times, even while undergoing medical procedures. It is extremely helpful in detecting any health conditions beforehand, before any such conditions cause severe discomfort to a patient. In June 2021, a major diagnostic testing solutions provider, Meridian BioScience, launched the Lyo-Ready RT-LAMP Mix for molecular detection of RNA viruses.
In recent years, near patient molecular solutions have emerged to address the medical concerns of individuals living in different regions and diseases affecting the human body. The main purpose of these products is to monitor the health of an individual as he or she travels across regions or crosses the border from one country to another. Depending on the disease concerned, the products are designed to be compatible with the standards of the healthcare organization of the country from where the individual has moved. The products are made available for use in clinical trials conducted by pharmaceutical companies and other institutions. In June 2021, the diagnostic testing company, BGI Americas, partnered with Advaite, a bio-tech company, to enhance the molecular testing solutions of the former.
Some of the factors pushing the near patient molecular solution market are increased use of residence point-of-care equipment, technological advancements with a trend for quicker and easier-to-use devices, and the rising rates of illnesses such as heart disease and diabetes in emerging nations. Additionally, the near patient molecular solution market is being propelled by the higher demand for home healthcare services and an increase in the number of geriatric patients with various chronic diseases.
Based on regions, North America led the near patient molecular solution market in the view of favorable reimbursement rules for diagnostic techniques and a large number of clinical trials examining the efficacy. Similarly, the lack of clinical diagnosing facilities have paved a way for local participants to provide near patient monitoring in the Asia Pacific region, which is projected to broaden the growth aspects of the near patient molecular solution market.
However, due to a decrease in the number of patient visits and the fact that hospitals have redirected their healthcare supplies and priority to the administration of COVID-19 cases, there has been a considerable drop in demand for regular diagnostic testing equipment or kits.
Top Key Players Include In Near Patient Molecular Solution Market: Abbott Laboratories, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., and GenMark Diagnostics.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/47
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Near Patient Molecular Solution Market is Growing Rapidly with Current and Future Business Opportunities appeared first on Gatorledger.
Explore more articles in the Research Reports category
